Showing results (191-200 of 290) with videos related to
Sort By:
Pageof 29
The Oncologist|May 13, 2017
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment OptionsLaurie M Gay, Sungeun Kim, Kyle Fedorchak, et al.Cancer Discovery|October 1, 2014
Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genesJuliann Chmielecki, Katherine E Hutchinson, Garrett M Frampton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinomaMarzia Capelletti, Michael E Dodge, Dalia Ercan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerSarah Croessmann, Luigi Formisano, Lisa N Kinch, et al.JCO Precision Oncology|September 11, 2020
Genomic Landscape of Appendiceal NeoplasmsCelina S-P Ang, John Paul Shen, Camille J Hardy-Abeloos, et al.Genome Medicine|May 31, 2013
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsMatthias Lechner, Garrett M Frampton, Tim Fenton, et al.Oncotargets and Therapy|December 15, 2015
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapyCasey B Williams, Caitlin McMahon, Siraj M Ali, et al.European Urology Focus|July 21, 2017
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy ResponseThai H Ho, Toni K Choueiri, Kai Wang, et al.Pageof 29